Hanxu Zhang

1.5k total citations · 1 hit paper
31 papers, 835 citations indexed

About

Hanxu Zhang is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Hanxu Zhang has authored 31 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 8 papers in Internal Medicine and 6 papers in Surgery. Recurrent topics in Hanxu Zhang's work include Atrial Fibrillation Management and Outcomes (9 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (6 papers). Hanxu Zhang is often cited by papers focused on Atrial Fibrillation Management and Outcomes (9 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (6 papers). Hanxu Zhang collaborates with scholars based in China and United States. Hanxu Zhang's co-authors include Yimin Cui, Qian Xiang, Xiaocong Pang, Zhiwei Qiu, Zhiyan Liu, Yanlun Gu, Nan Zhao, Ran Xie, He Xu and Guangyan Mu and has published in prestigious journals such as The Science of The Total Environment, Nutrients and Life Sciences.

In The Last Decade

Hanxu Zhang

29 papers receiving 822 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting integrin pathways: mechanisms and advances in therapy

2023 610 citations Xiaocong Pang, He Xu et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hanxu Zhang China	9	320	124	121	118	113	31	835
Zhiyan Liu China	8	332 1.0×	107 0.9×	93 0.8×	115 1.0×	136 1.2×	30	799
He Xu China	7	340 1.1×	125 1.0×	106 0.9×	131 1.1×	134 1.2×	15	773
Yanlun Gu China	7	324 1.0×	131 1.1×	110 0.9×	131 1.1×	127 1.1×	12	780
Kesheng Dai China	21	364 1.1×	145 1.2×	84 0.7×	64 0.5×	100 0.9×	65	1.1k
Agnieszka Strzelecka‐Kiliszek Poland	20	539 1.7×	179 1.4×	124 1.0×	64 0.5×	71 0.6×	45	1.0k
Cosetta Ravelli Italy	16	522 1.6×	101 0.8×	110 0.9×	66 0.6×	107 0.9×	44	822
Jin‐Hong Chang United States	19	589 1.8×	139 1.1×	234 1.9×	73 0.6×	240 2.1×	36	1.9k
Gurunathan Murugesan United States	13	423 1.3×	87 0.7×	95 0.8×	57 0.5×	58 0.5×	21	954
Marco De Giorgi Italy	15	482 1.5×	62 0.5×	73 0.6×	109 0.9×	93 0.8×	54	945

Countries citing papers authored by Hanxu Zhang

Since Specialization

Citations

This map shows the geographic impact of Hanxu Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanxu Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanxu Zhang more than expected).

Fields of papers citing papers by Hanxu Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanxu Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanxu Zhang. The network helps show where Hanxu Zhang may publish in the future.

Co-authorship network of co-authors of Hanxu Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Hanxu Zhang. A scholar is included among the top collaborators of Hanxu Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanxu Zhang. Hanxu Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cai, Shijiao, Yanyan Chen, Jing Zhang, et al.. (2024). Luteolin exerts anti‐tumour immunity in hepatocellular carcinoma by accelerating CD8⁺ T lymphocyte infiltration. Journal of Cellular and Molecular Medicine. 28(17). e18535–e18535. 6 indexed citations

Zhang, Hanxu, Yanyan Chen, Shuo An, et al.. (2024). Association Between Prior Antiplatelet Therapy and Prognosis in Patients With Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis. Clinical Therapeutics. 46(11). 905–915.

Liu, Zhiyan, Longtu Li, Hanxu Zhang, et al.. (2023). Platelet factor 4(PF4) and its multiple roles in diseases. Blood Reviews. 64. 101155–101155. 22 indexed citations

Li, Wenhui, Mingli Gong, Yanlun Gu, et al.. (2023). Risk of venous thromboembolism with janus kinase inhibitors in inflammatory immune diseases: a systematic review and meta-analysis. Frontiers in Pharmacology. 14. 1189389–1189389. 23 indexed citations

Pang, Bo, Tian Xie, Zhonghua Ning, et al.. (2023). Invasion patterns of Spartina alterniflora: Response of clones and seedlings to flooding and salinity—A case study in the Yellow River Delta, China. The Science of The Total Environment. 877. 162803–162803. 7 indexed citations

Liu, Zhiyan, Guangyan Mu, Hanxu Zhang, et al.. (2023). Integrated Pharmacokinetics/Pharmacodynamics Model and Simulation of the Ticagrelor Effect on Patients with Acute Coronary Syndrome. Clinical Pharmacokinetics. 62(3). 435–447. 1 indexed citations

Pang, Xiaocong, He Xu, Zhiwei Qiu, et al.. (2023). Targeting integrin pathways: mechanisms and advances in therapy. Signal Transduction and Targeted Therapy. 8(1). 1–1. 610 indexed citations breakdown →

Zhang, Hanxu, Shuang Zhou, Zhiyan Liu, et al.. (2022). Ferroptosis of Endothelial Cells in Vascular Diseases. Nutrients. 14(21). 4506–4506. 22 indexed citations

Wu, Hao, Qing Xia, Yue Pan, et al.. (2022). Web Crawling and mRNA Sequencing Analyze Mechanisms of Photobiomodulation. Photobiomodulation Photomedicine and Laser Surgery. 40(4). 252–260. 3 indexed citations

10.

Zhang, Zhuo, Hanxu Zhang, Ling Xu, et al.. (2022). miRNAs as therapeutic predictors and prognostic biomarkers of neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis. Breast Cancer Research and Treatment. 194(3). 483–505. 13 indexed citations

11.

Zhang, Hanxu, Zhuo Zhang, Zhiyan Liu, et al.. (2022). Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic–pharmacodynamic profiles of rivaroxaban. Human Genomics. 16(1). 72–72. 6 indexed citations

12.

Zhang, Zhuo, Hanxu Zhang, Chao Li, et al.. (2021). Circulating microRNAs as indicators in the prediction of neoadjuvant chemotherapy response in luminal B breast cancer. Thoracic Cancer. 12(24). 3396–3406. 18 indexed citations

13.

Mu, Guangyan, Hanxu Zhang, Zhiyan Liu, et al.. (2021). Standard- vs. low-dose rivaroxaban in patients with atrial fibrillation: a systematic review and meta-analysis. European Journal of Clinical Pharmacology. 78(2). 181–190. 2 indexed citations

14.

Mu, Guangyan, Jiayi Wang, Zhiyan Liu, et al.. (2021). Association between smokeless tobacco use and oral cavity cancer risk in women compared with men: a systematic review and meta-analysis. BMC Cancer. 21(1). 960–960. 20 indexed citations

15.

Zhang, Hanxu, Zhiyan Liu, Guangyan Mu, et al.. (2020). Diagnostic performance of coagulation indices for direct oral anticoagulant concentration. Thrombosis Research. 195. 171–179. 8 indexed citations

16.

Xiang, Qian, Zhiyan Liu, Yanyan Yu, et al.. (2020). Osteomalacia and renal failure due to Fanconi syndrome caused by long-term low-dose Adefovir Dipivoxil: a case report. BMC Pharmacology and Toxicology. 21(1). 43–43. 2 indexed citations

17.

Liu, Zhiyan, Hanxu Zhang, Qiufen Xie, et al.. (2020). Different Coagulation Indicators in Predicting Clinical Outcomes for Patients With Direct Oral Anticoagulants: A Systematic Review and Meta-analysis. Clinical Therapeutics. 42(10). 2066–2081.e9. 4 indexed citations

18.

Liu, Zhiyan, Qiufen Xie, Qian Xiang, et al.. (2020). Anti-FXa-IIa activity test in Asian and its potential role for drug adherence evaluation in patients with direct oral anticoagulants: a nationwide multi-center synchronization study. Cardiovascular Diagnosis and Therapy. 10(5). 1293–1302. 5 indexed citations

19.

Zhang, Hanxu, Qian Xiang, Zhiyan Liu, et al.. (2020). Genotype‐guided antiplatelet treatment versus conventional therapy: A systematic review and meta‐analysis. British Journal of Clinical Pharmacology. 87(5). 2199–2215. 6 indexed citations

20.

Mu, Guangyan, Qian Xiang, Shuang Zhou, et al.. (2020). Efficacy and Safety of PCSK9 Monoclonal Antibodies in Patients at High Cardiovascular Risk: An Updated Systematic Review and Meta-Analysis of 32 Randomized Controlled Trials. Advances in Therapy. 37(4). 1496–1521. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact